LabConnect Launches Data Integration Services
Seattle, WA. - LabConnect, a leading provider of highly customized global central laboratory and early development services to biopharmaceutical, medical device and contract research organizations, has announced the launch of its data integration services, which help sponsors coordinate complex, high-volume data collection and management from multiple laboratories’ data sources.
LabConnect’s enhanced, comprehensive data management capabilities streamline clinical trials by developing an infrastructure and coordinating logistics for programming, coding, cleaning and conditioning data that comes from a variety of sources.
By mapping and assembling the disparate data sources, standardizing data formats and merging, LabConnect provides superior data consistency, accuracy and usability. These outsourced solutions save sponsor resources and are particularly useful for delivering cohesive data for clinical projects, especially where timelines can be challenging.
“LabConnect’s robust data management services and tools provide sponsors improved speed, quality and continuity in their data,” said Eric Hayashi, president and CEO. “Data quality is ensured and documentation approved by the sponsor. We can often provide these services to our clients at a lower cost and with a faster turnaround than they can achieve keeping the tasks in-house, allowing them to remain focused on the core objectives of their clinical innovation.”
For more information about data integration and additional service areas, visit labconnectllc.com.
About LabConnect, LLC
Founded in 2002, LabConnect provides global central laboratory services including routine and specialized laboratory testing, kit building, sample management, data management, biorepository and scientific support services for biopharmaceutical, medical device and CRO clients. LabConnect’s unique combination of state-of-the-art technology, world-class laboratories, easy access to major and emerging markets and extensive specialized testing expertise means that drug development companies can rely on one provider for all their central laboratory and early development service needs, from preclinical through Phase IV. Learn more at www.labconnectllc.com or connect with LabConnect on LinkedIn.
Empowering Sites and Patients: The Impact of Personalized Support in Clinical Trials
November 26th 2024To meet the growing demands of clinical research, sponsors must prioritize comprehensive support models, such as clinical site ambassadors and patient journey coordinators, who can address operational challenges and improve site relationships, patient satisfaction, and overall trial efficiency.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
FDA Finalizes Decentralized Clinical Trial Guidance
November 25th 2024The FDA's guidance is part of a broader effort to modernize clinical trials, improve efficiency, reduce participant burden, and expand access, particularly for underrepresented populations and those in geographically or economically constrained areas.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
